U.S. energy royalty trusts have been great income investments over the past decade, but buying high yields at prices above underlying asset value can be dangerous to your wealth. Read More
Analyst Articles
Investing Daily's investment experts share some intimate details about their investment firsts and what lessons they learned. Read More
Gilead Sciences (NasdaqGS: GILD) may lead the race to offer an all-oral treatment for Hepatitis C liver disease, but several other drug companies are also in the hunt. Read More
The stock market is near four-year highs, but that hasn't stopped some stocks from plunging. Jim discusses three such stocks, only one of which is a speculative buy. Read More
August means 13F filing season, which allows us to peek into the minds of the world's greatest investors. Consumer staples and technology are in, while Citigroup is out. Read More
If you are concerned about a market correction or worse, investing in companies that are influenced by women is a wise move. And you might outperform in bull markets, too! Read More
As a result of the market's strong uptrend, two of the three August covered calls need to be rolled at debits. Read More
Although the demands of motherhood in raising small children could detrimentally affect the performance of female CEOs, academic research points to a completely unrelated reason. Read More
As one of the largest generators of electricity in the US, this utility has experienced a rise in share price as risk-averse investors seek dividend-paying companies that offer essential services. Once its shares eventually revert to trading at a more rational level, the income generated from selling a covered call should offset some of that decline. Read More
This top global producer of spirits could soon find its growth impaired by a slowdown in the developed world. With shares of its stock likely at a near-term peak, long-term investors can get paid to bide their time by selling a covered call. Read More